C

Cerus Corp
D

CERS

1.80500
USD
-0.05
(-2.43%)
مغلق
حجم التداول
90,351
الربح لكل سهم
-0
العائد الربحي
-
P/E
-16
حجم السوق
335,216,324
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    ABBV
    ABBV
    -3.460
    (-2.00%)
    169.130 USD
    A
    ADPT
    0.54000
    (7.23%)
    8.01000 USD
    C
    CRSP
    2.740
    (6.61%)
    44.200 USD
    E
    EDIT
    0.15000
    (12.50%)
    1.35000 USD
    MRNA
    MRNA
    2.600
    (7.24%)
    38.490 USD
    N
    NTRA
    4.640
    (2.77%)
    171.900 USD
    P
    PSTG
    2.215
    (3.16%)
    72.300 USD
    REGN
    REGN
    -7.47
    (-1.09%)
    679.85 USD
    T
    TDOC
    0.38500
    (4.06%)
    9.87500 USD
    المزيد
الأخبار
المقالات

العنوان: Cerus Corp

القطاع: Healthcare
الصناعة: Medical Devices
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.